Bioequivalence between innovator and generic tacrolimus in liver and kidney transplant recipients: A randomized, crossover clinical trial.

about

Bioequivalence between innovator and generic tacrolimus in liver and kidney transplant recipients: A randomized, crossover clinical trial.

Item

http://www.wikidata.org/entity/Q47152860

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Bioequivalence between innovat ...... zed, crossover clinical trial.

@en

Bioequivalence between innovat ...... zed, crossover clinical trial.

@nl

type

Item

label

Bioequivalence between innovat ...... zed, crossover clinical trial.

@en

Bioequivalence between innovat ...... zed, crossover clinical trial.

@nl

prefLabel

Bioequivalence between innovat ...... zed, crossover clinical trial.

@en

Bioequivalence between innovat ...... zed, crossover clinical trial.

@nl

P1476

Bioequivalence between innovat ...... zed, crossover clinical trial.

@en

P2093

Eileen C King

http://www.w3.org/2001/XMLSchema#string

Jelena Klawitter

http://www.w3.org/2001/XMLSchema#string

Tsuyoshi Fukuda

http://www.w3.org/2001/XMLSchema#string

Uwe Christians

http://www.w3.org/2001/XMLSchema#string

Wenlei Jiang

http://www.w3.org/2001/XMLSchema#string

Yuanshu Zou

http://www.w3.org/2001/XMLSchema#string

P2860

Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support

Comparing generic and innovator drugs: a review of 12 years of bioequivalence data from the United States Food and Drug Administration.

Sample size determination for bioequivalence assessment by means of confidence intervals.

Mechanisms of clinically relevant drug interactions associated with tacrolimus.

A pharmacokinetic and clinical review of the potential clinical impact of using different formulations of cyclosporin A. Berlin, Germany, November 19, 2001.

Presentation of results from bioequivalence studies.

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP3A5 Genotype and Tacrolimus Dosing.

Investigation of CYP 3A5 and ABCB1 gene polymorphisms in the long-term following renal transplantation: Effects on tacrolimus exposure and kidney function.

A randomized pharmacokinetic study of generic tacrolimus versus reference tacrolimus in kidney transplant recipients

Generic drug immunosuppression in thoracic transplantation: an ISHLT educational advisory.

P304

e1002428

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PMED.1002428

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-11-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29135993

http://www.w3.org/2001/XMLSchema#string

P932

5685573

http://www.w3.org/2001/XMLSchema#string